My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
November 2017
IDSA Launches Antimicrobial Stewardship Centers of Excellence Program

Providence Saint John’s Health Center of Santa Monica, California, and Summa Health of Akron, Ohio, are the first recipients of IDSA’s Antimicrobial Stewardship Centers of Excellence (CoE) designation.

The program, launched this month, recognizes institutions that achieve standards established by the Centers for Disease Control and Prevention (CDC) for antimicrobial stewardship programs led by infectious diseases physicians and ID-trained pharmacists.

“IDSA is committed to infectious diseases-led antimicrobial stewardship programs as an essential component in the fight against antimicrobial resistance, which leads to more than 23,000 deaths per year and over $20 billion in unnecessary health care costs,” said IDSA President Paul Auwaerter, MD, MBA, FIDSA. “The IDSA Antimicrobial Stewardship Centers of Excellence program recognizes institutions that lead in establishing highly effective antimicrobial stewardship programs that help clinicians give their patients optimal anti-infective therapies.”

The core criteria for the IDSA Antimicrobial Stewardship Centers of Excellence were developed by a workgroup of ID physicians and ID-trained pharmacists and build upon the criteria detailed in the CDC’s Core Elements of Hospital Antibiotic Stewardship Programs. IDSA’s CoE program places particular emphasis on an institution’s ability to implement stewardship protocols through its electronic health record (EHR) system, as well as provide ongoing education to its medical staff.

The goals of the program are to not only recognize those who have achieved high standards in their stewardship programs, but also to highlight the value of stewardship in preserving the effectiveness of the vulnerable supply of antibiotics.

All health systems are welcome to apply for the CoE designation and can learn more about the criteria at:

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

HIVMA Releases Guideline on HIV and Chronic Pain
ACIP Makes New Recommendations on Shingles, Mumps Vaccines
Weighing in on HHS Report on Vaccine Innovation
Updates on NIHís Next Generation Researchers Initiative
IDSA to UHC: Donít Deny Payment for Cognitive Services
Reimbursement for Telemedicine Could Get Easier
How to Stay Abreast of CMSís Quality Payment Program
IDSA Remains Committed to Fighting Antimicrobial Resistance
FY2018 Funding News
IDSA Continues to Press for Diagnostics Reimbursement
FDA Public Workshop on Antimicrobial Susceptibility Tests
IDSA Member Testifies at New York State Hearing on Lyme Disease
Science Speaks Covers IDWeek, Union World Conference on Lung Health
Congressional Study Tour to CDC Global Health
Fellowship in Stewardship and Resistance Receives CDC Funding
HIVMA Clinical Fellowship and Medical Students Program
PCORI Funding Announcement: Community-Acquired Pneumonia
Maintaining Our Momentum
IDSA Launches Antimicrobial Stewardship Centers of Excellence Program
Updated Guideline on Infectious Diarrhea Now Available
IDWeek 2017 Recap
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.